
Celcuity Inc.
NASDAQ:CELC
11.78 (USD) • At close June 5, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Celcuity Inc. |
Symbool | CELC |
Munteenheid | USD |
Prijs | 11.78 |
Beurswaarde | 446,066,192 |
Dividendpercentage | 0% |
52-weken bereik | 7.575 - 19.77 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Brian F. Sullivan |
Website | https://www.celcuity.com |
An error occurred while fetching data.
Over Celcuity Inc.
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)